ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Gary · Oxygen transplant

Patient Basic Information Patient: Mr. Gary (Gary Ramirez) Nationality: Lithuania Disease Diagnosis: Heart Transplant Diagnostic Hospital: H0C Treatment Program: Blood stem cell transplant + chemotherapy Dates of hospitalization: 75 days Treatment cost: about RMB 550,565 Treatment effect: Quality of life improvement Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs.

After 75 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and various test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results Eventually the patient's quality of life improved. When discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through a remote follow-up system.

'Mr. LiuGary, the experts criticized this case as a typical case of cross-border suspected seriousness clinical disease. Liu4 is based on a multidisciplinary collaborative mechanism that developed a blood stem cell transplant + chemotherapy program for heart transplantation, which reflects the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated.

(Figure from Liu5 official news reports and medical scenarios)

立陶宛,心脏移植,上海交通大学医学院附属仁济医院,国际医疗,来华就医,中国医疗